Clinical trial

COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias

NCT04416438

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-05-18

PhaseN/A

Study timeline

Study start (actual)2020-05-18Date precision: day

Registry last updated2022-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Myeloproliferative Neoplasmunresolved

COVID-19 Infectionunresolved

Interventions

Sponsors & collaborators

French Innovative Leukemia Organisationlead sponsor

French Intergroup of Myeloproliferative syndromescollaborator

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04416438 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.